Q2 2025 Holdings
Filed 2025-08-14 | 63 holdings | $134.5M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2025-08-15) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ishares TRA | PUT | 464287954 | $7.4M | 200,000 | 5.5% |
| Ishares TRPut | PUT | 464287954 | $7.4M | 200,000 | 5.5% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $6.7M | 155,533 | 5.0% |
| Guardant Health Inc(GH) | COM | 40131M109 | $5.1M | 98,182 | 3.8% |
| Geron Corp(GERN) | COM | 374163103 | $4.8M | 3,414,377 | 3.6% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $4.8M | 121,116 | 3.6% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $4.8M | 27,000 | 3.5% |
| Astrazeneca PLC(AZN)PutA | SPONSORED ADR | 046353108 | $3.9M | 28,362 | 2.9% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $3.9M | 28,362 | 2.9% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $3.8M | 533,647 | 2.8% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $3.8M | 115,817 | 2.8% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $3.7M | 397,846 | 2.7% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $3.6M | 4,673 | 2.7% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $3.5M | 41,641 | 2.6% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $3.5M | 6,358 | 2.6% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $3.2M | 61,356 | 2.4% |
| Natera Inc(NTRA) | COM | 632307104 | $3.2M | 18,650 | 2.3% |
| Akero Therapeutics Inc(AKRO)PutA | COM | 00973Y108 | $3.1M | 58,579 | 2.3% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $3.1M | 58,579 | 2.3% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $3.1M | 444,949 | 2.3% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $3.0M | 84,339 | 2.2% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $2.9M | 308,298 | 2.1% |
| Verastem Inc(VSTM) | COM NEW | 92337C203 | $2.5M | 599,900 | 1.9% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $2.5M | 59,002 | 1.8% |
| Penumbra Inc(PEN) | COM | 70975L107 | $2.3M | 9,000 | 1.7% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $2.3M | 233,426 | 1.7% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $2.3M | 153,278 | 1.7% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $2.2M | 166,944 | 1.6% |
| Acadia Pharmaceuticals Inc(ACAD)CallA | COM | 004225108 | $2.0M | 93,222 | 1.5% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $2.0M | 93,222 | 1.5% |
| Nektar TherapeuticsA | CALL | 640268906 | $1.9M | 75,000 | 1.4% |
| Nektar TherapeuticsCall | CALL | 640268906 | $1.9M | 75,000 | 1.4% |
| Waystar Hldg Corp(WAY) | COM | 946784105 | $1.9M | 46,900 | 1.4% |
| Corbus Pharmaceuticals Hldgs(CRBP) | COM NEW | 21833P301 | $1.9M | 277,317 | 1.4% |
| 10X Genomics Inc(TXG) | CL A COM | 88025U109 | $1.9M | 163,658 | 1.4% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $1.9M | 195,933 | 1.4% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $1.9M | 226,060 | 1.4% |
| Universal Hlth Svcs Inc(UHS) | CL B | 913903100 | $1.8M | 10,100 | 1.4% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $1.8M | 76,700 | 1.3% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $1.8M | 62,700 | 1.3% |
| Cencora Inc(COR)CallA | COM | 03073E105 | $1.8M | 6,000 | 1.3% |
| Cencora Inc(COR) | COM | 03073E105 | $1.8M | 6,000 | 1.3% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $1.7M | 98,600 | 1.3% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $1.6M | 124,470 | 1.2% |
| Travere Therapeutics IncCall | CALL | 89422G907 | $1.6M | 110,000 | 1.2% |
| Travere Therapeutics IncA | CALL | 89422G907 | $1.6M | 110,000 | 1.2% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $1.5M | 172,883 | 1.2% |
| Karyopharm Therapeutics Inc | NOTE 3.000%10/1 | 48576UAA4 | $1.5M | 2,000,000 | 1.1% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $1.5M | 73,000 | 1.1% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $1.4M | 2,000,000 | 1.1% |